Skip to main content
. 2021 Feb 5;10(4):607. doi: 10.3390/jcm10040607

Figure 1.

Figure 1

Risk-based treatment of membranous nephropathy (adapted from Clinical Practice Guidelines for the management of glomerulonephritis [10]).